Excretion of methylergometrine (methylergonovine) into the human breast milk.
Methylergometrine concentrations in the maternal plasma and breast milk were determined by a radioimmunoassay during continuous treatment with 0.125 mg of methylergometrine 3 times daily. On the fifth postpartum day at 8:00 a.m. the patients (n=8) took 2 tablets of Myomergin (0.250 mg of methylergometrine) orally, and the levels in the plasma and milk were determined at 1 and 8 hr after the drug administration. Measurable amounts of the drug were found only in 5 out of 16 milk samples. It was concluded that this oxytocic drug does not appear in the breast milk in quantities sufficient to affect the infant. No cumulation in the plasma or in the breast milk was found.
D000328:Adult; D005260:Female; D006801:Humans; D008755:Methylergonovine / Q000097:blood / Q000378:metabolism*; D008895:Milk, Human / Q000378:metabolism*; D013997:Time Factors
D008755:Methylergonovine